IMMY

?? February 28th is Rare Disease Day – We're Shedding Light on Fungal Infections Fungal infections are often misdiagnosed or overlooked, leading to delayed or inadequate treatment—especially in vulnerable populations. Their non-specific symptoms and limited awareness make early diagnosis challenging, yet timely intervention is crucial to saving lives. ?? Why Are Fungal Infections Overlooked? ? Mimic bacterial & viral infections – Often mistaken for pneumonia and other respiratory diseases. ? Underdiagnosed & misclassified – Many cases go unrecognized, leading to inaccurate reporting. ? Slow & insensitive traditional tests – Cultures take too long and often miss infections. ? Limited awareness & expertise – Many healthcare providers lack training in mycology. ? Healthcare disparities & resource limits – Many regions lack access to fungal diagnostics. ? The Consequences of Misdiagnosis ? Inappropriate therapy – Delayed antifungal treatment and unnecessary antibiotics. ? Higher mortality – Some invasive fungal infections have fatality rates over 50% if untreated. ? Rising antifungal resistance – Misdiagnosis fuels resistance in fungal pathogens. ??Who Is Most at Risk? ? Immunocompromised patients – Cancer, HIV/AIDS, and transplant patients are highly vulnerable. ? Certain racial & ethnic groups – Some populations are disproportionately affected. ? High-risk jobs or endemic regions – Occupational exposure increases infection risks. ?? How Can We Improve Fungal Diagnosis? ? Educate healthcare providers to recognize fungal infections early. ? Expand rapid diagnostics – IMMY’s antigen & molecular tests detect infections in hours, not days. ? Enhance disease surveillance to track emerging threats. ? Follow treatment guidelines to improve patient care. ? Early Screening Saves Lives Fungal infections are treatable—but only if diagnosed in time. IMMY’s rapid, accurate diagnostics for Cryptococcus, Candida, Aspergillus, and Pneumocystis help clinicians detect infections sooner and start life-saving treatment faster. On Rare Disease Day, let’s raise awareness and advocate for better fungal disease recognition and diagnostics. #ThinkFungus early—because timely diagnosis saves lives. Learn more about this important cause: https://hubs.ly/Q037D-ch0 #RareDiseaseDay #IMMY #FungalInfections #InfectiousDisease

Real Impact. Real Results. Dr. Terezinha do Menino Jesus Silva Leitao from the Federal University of Ceará shares how IMMY’s Histoplasma GM Enzyme Immunoassay is changing lives: "We had an excellent experience with ELISA for diagnosing disseminated histoplasmosis in AIDS patients in Ceará. We decreased mortality in those cases. Places that had never identified histoplasmosis before are now diagnosing it thanks to this test." Reliable diagnostics save lives. Learn more: https://hubs.ly/Q038GnFS0 #FungalDiagnostics #Histoplasmosis #SavingLives

Fungal Education Fridays: New Global Guidelines for Candidiasis Diagnosis & Management The European Confederation of Medical Mycology (ECMM), in collaboration with International Society of Human and Animal Mycology (ISHAM and the American Society for Microbiology (ASM), has released updated global guidelines for the diagnosis and management of candidiasis. Why does this matter? Candida species remain a leading cause of hospital-acquired fungal infections, contributing to significant morbidity and mortality. While mucocutaneous candidiasis affects many individuals, invasive infections like candidaemia pose severe risks to immunocompromised and critically ill patients. Emerging threats such as Candida auris and fluconazole-resistant Candida parapsilosis continue to challenge clinicians worldwide. Key updates from the guidelines: ?? Revised taxonomy—Recent classification changes may impact clinical decision-making. ?? Antifungal resistance—New data highlight growing resistance patterns in Candida infections. ?? Diagnostics & molecular testing—Commercial molecular assays are preferred over in-house methods, particularly for detecting problematic species like Candida auris. While molecular testing is not yet strongly recommended for all patient populations, its role alongside biomarkers is gaining moderate support, especially for rapid species identification. ?? IMMY provides commercially available molecular assays for Candida species and Candida auris, helping laboratories meet the increasing need for accurate and timely fungal diagnostics. Additionally, IMMY's AurisID allows direct detection of C. auris from surveillance samples without prior DNA extraction. ?? Discover our solutions: https://hubs.ly/Q037m23d0 and https://hubs.ly/Q037mBHH0 ?? Read the full guidelines: https://hubs.ly/Q037mDKG0 #FungalEducationFridays #Candidiasis #FungalDiagnostics #CandidaAuris #AntifungalResistance #InfectiousDiseases #ThinkFungus

IMMY is at Ethio Health 2025 in Addis Ababa! Connect with John Bannister and Shadrack Were. at Booth G2.2 Friday and Saturday to explore our life-saving, rapid fungal diagnostics. Ethiopia’s largest healthcare trade fair is the place for innovation & collaboration—see you there! #IMMY #EthioHealth2025 #FungalDiagnostics #ThinkFungus

Invasive Aspergillosis is a serious threat—with over 30 million at-risk individuals annually, early detection is critical. ? Time matters. IMMY’s Aspergillus GM LFA delivers highly sensitive and specific results in just 45 minutes, enabling clinicians to test more often and initiate timely treatment. ?? Proven Performance ? 97% Sensitivity | ? 98% Specificity Backed by clinical data, IMMY’s LFA is a trusted solution for rapid and accurate Aspergillus detection. ?? The IMMY Aspergillus galactomannan LFA has been suggested as a diagnostic tool in the 2020 ECMM CAPA-IAA-ICU management algorithm guidelines. Detect sooner. Treat faster. Improve patient outcomes. ??See the difference: https://hubs.ly/Q037mYVn0 #FungalDiagnostics #Aspergillus #RapidTesting #SavingLives #ThinkFungus

?? IMMY is heading to Ethio Health 2025 in Addis Ababa! IMMY representatives, John Bannister and Shadrack Were., will be exhibiting from Feb. 20-22 at Booth G2.2, showcasing IMMY’s life-saving, rapid, and accurate fungal diagnostics. As Ethiopia’s largest healthcare, medical, and pharmaceutical trade fair, Ethio Health is the premier platform for innovation, market expansion, and collaboration in Africa’s growing healthcare sector. Join us to explore how IMMY’s innovative solutions are transforming fungal disease diagnostics and improving patient outcomes. See you there! #IMMY #EthioHealth2025 #ClinicalMicrobiology #InfectiousDisease #FungalDiagnostics #ThinkFungus

?? IMMY is Hiring for Two Key Positions! At IMMY, we’re on a mission to improve health and save lives through world-class fungal diagnostics. Behind every test we produce, there’s a face, a story, a family, and a heritage. Now, we’re growing our team and looking for passionate individuals to help us make an impact! ?? Open Positions: ?? Software Engineer – Develop and enhance cutting-edge software solutions that support our diagnostics and internal operations. ?? Director of Information Technology (IT) – Oversee IMMY’s IT infrastructure and ensure the security, efficiency, and innovation of our tech operations. ?? Who We Are: IMMY is built on shared values: ? Humble – We embrace feedback, prioritize collective success, and treat everyone with dignity. ? Driven – We operate with urgency, challenge the status quo, and seek innovative solutions. ? Collaborative – We work together, value diverse perspectives, and foster positive relationships. Why Join IMMY? ?? Competitive health benefits & wellness perks ?? Generous PTO ?? 401K Safe Harbor plan & tuition reimbursement ?? A fun, family-friendly culture with team events, monthly Pancakes & Presentations, and more! Apply today and be part of a team making a global impact! ?? https://hubs.ly/Q0377xnD0 #NowHiring #IMMYCareers #SoftwareEngineer #SalesJobs #ITDirector #JoinOurTeam

? Rapid Detection. Life-Saving Impact. Cryptococcal meningitis remains a major threat to people living with HIV/AIDS, with over 220,000 cases and 181,000 deaths worldwide annually. Early detection is critical. IMMY’s CrAg LFA delivers highly sensitive and specific results in just 10 minutes—with no pretreatment required and only 1 minute of hands-on time. Simple. Fast. Reliable. Learn more: https://hubs.ly/Q036cT_q0 #CryptococcalMeningitis #FungalDiagnostics #CrAgLFA #HIVCare #IMMY #ThinkFungus #CrAgLFA

?? This year marks the 10th anniversary of International Day of Women and Girls in Science! At IMMY, we are proud to celebrate the incredible women who drive innovation, research, and impact in fungal diagnostics. Women remain underrepresented in STEM, but at IMMY, over half of our team is made up of remarkable women leading the way. By breaking barriers and championing inclusion, they are shaping the future of science and healthcare. ?? Join us in recognizing their contributions and advocating for greater gender equality in science! ???? Learn more about this important mission: https://hubs.ly/Q03623Gb0 #WomenInScienceDay #IMMY #STEM #WomenInSTEM

Melissa Copas and Robyn Crow are kicking off First Coast IDCM and ready to connect! ?? Stop by the IMMY booth to explore our rapid, accurate, and innovative fungal diagnostics. Let’s improve health and save lives together! #IMMY #ClinicalMicrobiology #FungalInfections #ThinkFungus #TestFungus #FirstCoast